TTK Healthcare (BOM:507747) E10: ₹87.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507747 TTK Healthcare Ltd BOM:507747
77 GF Score
Price ₹1,135.55
GF Value ₹1,440.94
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TTK Healthcare E10?

TTK Healthcare BOM:507747 +5.09% 77 E10 is ₹87.71 as of Jun. 2026. GuruFocus rates BOM:507747 with a GF Score™ of 77/100 and a GF Value™ of ₹1,440.94 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TTK Healthcare's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹15.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹87.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, TTK Healthcare's average E10 Growth Rate was 4.50% per year. During the past 3 years, the average E10 Growth Rate was 5.60% per year. During the past 5 years, the average E10 Growth Rate was 30.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of TTK Healthcare was 43.90% per year. The lowest was 5.60% per year. And the median was 43.30% per year.

As of today (2026-08-29), TTK Healthcare's current stock price is ₹1135.55. TTK Healthcare's E10 for the quarter that ended in Jun. 2026 was ₹87.71. TTK Healthcare's Shiller PE Ratio of today is 12.95.

During the past 13 years, the highest Shiller PE Ratio of TTK Healthcare was 30.65. The lowest was 8.97. And the median was 17.48.


TTK Healthcare  (BOM:507747) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TTK Healthcare's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1135.55/87.71
=12.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of TTK Healthcare was 30.65. The lowest was 8.97. And the median was 17.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


TTK Healthcare E10 Related Terms


TTK Healthcare E10 Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare E10 Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.73 72.71 77.56 82.24 85.73

TTK Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.33 85.13 84.90 85.73 87.71

BOM:507747 vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, TTK Healthcare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's Shiller PE Ratio falls into.


BOM:507747
77GF Score
TTK Healthcare Ltd BOM:507747
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TTK Healthcare E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TTK Healthcare's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.06/167.3573*167.3573
=15.060

Current CPI (Jun. 2026) = 167.3573.

TTK Healthcare Quarterly Data

per share eps CPI Adj_EPS
201609 5.860 105.961 9.255
201612 4.600 105.196 7.318
201703 6.470 105.196 10.293
201706 -9.390 107.109 -14.672
201709 7.930 109.021 12.173
201712 15.770 109.404 24.124
201803 5.660 109.786 8.628
201806 5.580 111.317 8.389
201809 4.710 115.142 6.846
201812 3.460 115.142 5.029
201903 3.510 118.202 4.970
201906 2.580 120.880 3.572
201909 2.680 123.175 3.641
201912 3.170 126.235 4.203
202003 0.300 124.705 0.403
202006 -1.700 127.000 -2.240
202009 21.800 130.118 28.039
202012 5.440 130.889 6.956
202103 7.330 131.771 9.310
202106 4.240 134.084 5.292
202109 9.060 135.847 11.162
202112 8.610 138.161 10.429
202203 7.510 138.822 9.054
202206 425.230 142.347 499.941
202209 7.020 144.661 8.121
202212 8.490 145.763 9.748
202303 11.990 146.865 13.663
202306 11.090 150.280 12.350
202309 11.330 151.492 12.517
202312 9.130 152.924 9.992
202403 12.930 153.035 14.140
202406 22.350 155.789 24.010
202409 12.170 157.882 12.900
202412 11.840 158.323 12.516
202503 11.430 157.552 12.141
202506 9.200 159.755 9.638
202509 14.430 162.289 14.881
202512 7.450 163.281 7.636
202603 15.400 164.272 15.689
202606 15.060 167.357 15.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹87.71 mean?
TTK Healthcare (BOM:507747) has a E10 of ₹87.71 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TTK Healthcare and its competitors.
Is TTK Healthcare's E10 too high?
TTK Healthcare's current E10 is ₹87.71. Overall, TTK Healthcare has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's E10 compare to LLY and JNJ?
TTK Healthcare's E10 of ₹87.71 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TTK Healthcare and its competitors. TTK Healthcare's current E10 is ₹87.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,440.94, compared to a current price of ₹1,135.55 — trading 21.2% below its estimated fair value. The current E10 is ₹87.71. TTK Healthcare's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current E10 is ₹87.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹1,135.55 is trading 21.2% below its estimated GF Value™ of ₹1,440.94. GuruFocus considers TTK Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:507747:

  • E10: ₹87.71
  • GF Value™: ₹1,440.94 vs. price of ₹1,135.55 (21.2% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
77GF Score

Get the complete analysis for BOM:507747

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,135.55
Price
₹1,440.94
GF Value